DBV Technologies SA
XMUN:DBV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
D
|
DBV Technologies SA
XMUN:DBV
|
FR |
|
Rush Enterprises Inc
F:RUN
|
US |
|
C
|
Continental AG
MIL:CON
|
DE |
|
L
|
LVMH Moet Hennessy Louis Vuitton SE
XMUN:MOH
|
FR |
|
C
|
CITIC Securities Co Ltd
F:CI9
|
CN |
|
C
|
China Mobile Ltd
XHAM:CTM
|
CN |
|
G
|
Gold Fields Ltd
XMUN:EDGA
|
ZA |
|
W
|
Wells Fargo & Co
F:NWT
|
US |
|
F
|
FedEx Corp
XHAM:FDX
|
US |
|
Immunome Inc
NASDAQ:IMNM
|
US |
|
A
|
American Water Works Company Inc
XMUN:AWC
|
US |
|
Continental AG
F:CONA
|
DE |
|
International Paper Co
LSE:IPC
|
US |
|
O
|
Onto Innovation Inc
XMUN:NNM
|
US |
|
E
|
EQT Corp
F:EQ6
|
US |
|
C
|
China Minsheng Banking Corp Ltd
F:GHFH
|
CN |
|
Turkcell Iletisim Hizmetleri AS
F:TUL1
|
TR |
Bankruptcy Probability
DBV Technologies SA's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
DBV Technologies SA Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| FR |
|
DBV Technologies SA
PAR:DBV
|
841.4m EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
415.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
189.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
155.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
120.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
65.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
46.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
DBV Technologies SA's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, DBV Technologies SA has total debt of 5.4m USD. This includes both short-term (0 USD) and long-term (5.4m USD) debt.
You can find a full breakdown on its Balance Sheet.
